¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"central nervous system agents"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • circulatory system
    ¼øÈ¯°èÅë, ¼øÈ¯°è
  • closed drainage system
    ´ÝÈû¹èÃâÀåÄ¡
  • clotting system
    ÀÀ°í°èÅë
  • collecting system
    ÁýÇÕ°è
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • complement system
    º¸Ã¼°è, µµ¿òü°èÅë
  • conduction system
    Àüµµ°è
  • control system
    Á¦¾îÀåÄ¡
  • countercurrent system
    ¿ª·ù°è
  • culture system
    ¹è¾ç½Ã½ºÅÛ
  • cytochrome P-450 system
    ½ÃÅäÅ©·ÒP-450½Ã½ºÅÛ
  • cardiovascular system
    ½ÉÀåÇ÷°ü°èÅë, ½ÉÇ÷°ü°è
  • case payment system
    Æ÷°ý¼ö°¡Á¦
  • drug delivery system
    ¾à¹°Àü´Þü°è
  • dynamic system
    µ¿Àû°èÅë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • system analysis
    °èÅëºÐ¼®
  • biliary system
    ´ãµµ°è, ¾µ°³°èÅë
  • bioenergetic system
    »ý¹°¿¡³ÊÁö°è
  • blood group system
    Ç÷¾×Çü±º
  • breathing system
    È£ÈíÀåÄ¡
  • buffer system
    ¿ÏÃæ°è
  • capitation system
    ȯÀÚµî·ÏÁ¦
  • cardiovascular system
    ½ÉÀåÇ÷°ü°èÅë
  • case payment system
    Æ÷°ý¼ö°¡Á¦
  • chemoreception system
    È­Çмö¿ë°è
  • circle absorption system
    ¼øÈ¯Èí¼ö½Äȸ·Î
  • circuit system
    ¼øÈ¯½Äȸ·Î
  • circulatory system
    ¼øÈ¯°èÅë
  • closed drainage system
    ´ÝÈû¹èÃâÀåÄ¡
  • clotting system
    ÀÀ°í°èÅë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • gamma motoneuron system
    °¨¸¶¿îµ¿°è(¡­ê¡ÔÑͧ).
  • gas disposal system
    °¡½ºÃ³¸®ÀåÄ¡.
  • gastrointestinal system
    À§Àå°è.
  • gastrointestinal system
    À§Àå°è(êÖíóͧ).
  • gate control system
    °ü¹®Á¶Á¤ÀåÄ¡(μڦðàïÚíûöÇ).
  • general system theory
    ÀϹÝü°è(ÀÌ)·Ð(ìéÚõô÷ͧìµÖå)
  • genital system
    »ý½Ä°è(ßæãÖͧ).
  • genital system
    »ý½Ä°èÅë
  • genital system
    »ý½Ä±â°è(ßæãÖÐïͧ)
  • genitourinary system
    ºñ´¢»ý½Ä±â°èÅë(ù²èñßæãÖÐïͧ÷Ö).
  • genitourinary system
    ºñ´¢»ý½Ä±â°èÅë(ù²èñßæãÖÐïͧ÷Ö).
  • global budget system
    ÃѾ׿¹»êÁ¦, ÃѾװè¾àÁ¦.
  • guarantee system
    º¸ÁõÁ¦µµ(ËÓ̡̡̬).
  • h2o2-myeloperxidase-halide system
    °ú»êÈ­¼ö¼Ò-°ñ¼ö°ú»êÈ­È¿¼Ò-ÇÒ·Î°Õ °èÅë
  • hamatopoietic system
    Á¶Ç÷±â°ü(ðãúìÐïί)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • central anosmia
    ÁßÃß¼º ¹«Èİ¢Áõ
  • central anosmia
    ÁßÃß¼º ¹«Èİ¢Áõ(¡­Ùíö«ÊÆñø).
  • central aphasia
    ÁßÃß¼º ½Ç¾îÁõ(¡­ã÷åÞñø).
  • central areolar choroidal dystrophy
    Á߽ɼº¿øÇü¸Æ¶ô¸·ÀÌ¿µ¾ç(Áõ)
  • central artery cerebri mediae
    Áߺγúµ¿¸ÆÁß½ÉÁö.
  • central artery cerebri posterioris
    Èĺγúµ¿¸ÆÁß½ÉÁö.
  • central artery of retina
    ¸Á¸·Á߽ɵ¿¸Æ
  • central ataxia
    ÁßÃß¼º ¿îµ¿½ÇÁ¶Áõ(¡­ê¡ÔÑã÷ðàñø).
  • central attachment
    Á߽ɺÎÂø
  • central auditroy procelling disorder
  • central axis depth dose
    Áß½ÉÃà½ÉºÎ¼±·®
  • central blindness
    ÁßÃ߸Í(ñéõÒØî), ÁßÃ߽ð¢¼Ò½Ç(Áõ)(¡­ãÊÊÆá¼ã÷ñø).
  • central blindness
    ÁßÃß¼º¸Í(ñéõÒØî)
  • central blood pressure
    Áß½ÉÇ÷¾Ð
  • central bone
    (Á߽ɻÀ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
CNES chronic nervous exhaustion syndrome
ner nervous
CIS carcinoma in situ; catheter-induced spasm; central inhibitory state; Chemical Information Service; c...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
MEOS Microsomal Ethanol Oxidizing System
  = MFOS; Mixed Function Oxidase System
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
CCD Central Core Disease
CMCT Central Motor Conduction Time
CPG Central Pattern Generator
CPM Central Pontine Myelinolysis
CPU Central Processing Unit
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • central sequestrum
    Á᫐ ºÎ°ñ
  • central serous choroidopathy
    Á߽ɼº Àå¾× ¸Æ¶ô¸·º´Áõ
  • central somatosensory pathway
    ÁßÃß¼º ü¼º °¨°¢ °æ·Î, ÁßÃß Ã¼¼º °¨°¢ °æ·Î
  • central spindle
    Á᫐ ¹æÃß
  • central suppression
    ÁßÃß¼º ¾ïÁ¦, Á᫐ ¾ïÁ¦
  • central tegmental tract
    Á᫐ µÚÆÇ·Î
  • central transmission
    ÁßÃß Àü´Þ
  • central trigeminal sensory pathway
    ÁßÃß¼º »ïÂ÷ ½Å°æ °¨°¢Áö °æ·Î, Á߽ɼº »ïÂ÷ ½Å°æ °¨°¢Áö °æ·Î
  • central vein nutritional support
    Á᫐ Á¤¸Æ ¿µ¾ç ÁöÁö ¿ä¹ý
    ¹«±Õ ±â¼úÀ» »ç¿ëÇÏ¿© °æÇÇÀûÀ¸·Î À§Ä¡ÇÑ Á¤¸Æ³» µµ°üÀ» ÅëÇØ °¡Àå ÈçÈ÷ ÀüÇØÁø´Ù. »ó´ë Á¤¸ÆÀ¸·ÎÀÇ ÀûÀýÇÑ ¹èÄ¡´Â ¿ë¾×ÀÇ Åõ¿©¸¦ ½ÃÀÛÇϱâ Àü¿¡ ¹æ»ç¼±ÇÐÀûÀ¸·Î Áõ¸íµÈ´Ù. µµ°üÀº °æÇèÀÌ ÀÖ´Â °£È£ ¿ä¿ø¿¡ ÀÇÇØ Á¶½É½º·´°Ô À¯ÁöµÇ°í ¿µ¾ç ÁöÁö ¿ä¹ý À̿ܿ¡´Â »ç¿ëµÇÁö ¾Ê¾Æ¾ß ÇÑ´Ù.
  • central venous pressure
    Á᫐ Á¤¸Æ¾Ð
    ¿ì½É¹æ¿¡¼­ ÃøÁ¤ÇÑ Á¤¸Æ¾Ð. »óÇà ´ëÁ¤¸Æ³»·Î Ä«Å×Å͸¦ Á¤Áß ÁÖ Á¤¸ÆÀ» ÅëÇØ »ðÀÔÇÏ°í ±× ³¡¿¡ ¾Ð·Â°è¸¦ ºÎÂøÇÏ¿© ÃøÁ¤ÇÑ´Ù. ü¼øÈ¯°èÀÇ ¸ðµç Á¤¸Æ Ç÷¾×Àº ¿ì½É¹æÀ¸·Î Èê·¯µé¹Ç·Î ¿ì½É¹æ³»ÀÇ ¾Ð·ÂÀ» Á᫐ Á¤¸Æ¾ÐÀ̶ó°í ÇÑ´Ù. ¸»ÃÊ Á¤¸Æ Ç÷¾ÐÀº ÀÌ Á᫐ Á¤¸Æ Ç÷¾ÐÀÇ º¯È­¿¡ µû¶ó º¯ÇÑ´Ù.
  • central visual acuity
    Á᫐ ½Ã·Â
  • deafferented central neuron
    ±¸½É·Î Â÷´Ü Á߽ɼº ´º¿ì·±
  • deciduous central incisor
    À¯ÁßÀýÄ¡
  • lower central incisor
    ÇÏ¾Ç ÁßÀýÄ¡
    Ä¡±Ã¿¡¼­ °¡Àå ÀÛÀº Ä¡¾Æ·Î »ó¾Ç ÀýÄ¡¿Í ´Þ¸® ¼ø¼³°æÀÌ ±Ù¿ø½É°æ º¸´Ù ´õ ±»Àº ÇüÅÂÀ̸ç Àý´Ü¸éÀÌ Ä¡°üÀÇ ¼ø¼³Æø Áß¾Ó¿¡¼­ ¾à°£ ¼³ÃøÀ¸·Î Ä¡¿ìÃÄ ÀÖ°í »ó¾Ç ÁßÀýÄ¡¿Í 1Ä¡´ë 1Ä¡ÀÇ °ü°è¸¦ °®°í ÀÖ°í Ä¡°üÀÇ ±Ù, ¿ø½É¹ÝºÎ°¡ °ÅÀÇ ´ëĪÀ» ÀÌ·ç°í ÀÖ¾î ÁÂ, ¿ìÃø ±¸º°ÀÌ °¡Àå ¾î·Á¿î Ä¡¾ÆÀÌ´Ù.
  • upper central incisor
    »ó¾Ç ÁßÀýÄ¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
anti-obesity agents Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (niddm) to treat obesity.
(12 Dec 1998)
antiparasitic agents Drugs used to treat or prevent parasitic infections.
(12 Dec 1998)
antiparkinson agents Agents used in the treatment of parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
(12 Dec 1998)
anti-platelet agents Medications that, like aspirin, reduce the tendency of platelets in the blood to clump and clot.
(12 Dec 1998)
antiplatyhelmintic agents Agents used to treat cestode, trematode, or other flatworm infestations in man or animals.
(12 Dec 1998)
antiprotozoal agents Agents destructive to protozoans or that check their growth or reproduction, especially those causing protozoan infections in man and animal.
(12 Dec 1998)
antipsychotic agents Agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in schizophrenia, senile dementia, transient psychosis following surgery or myocardial infarction, etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
(12 Dec 1998)
antipsychotic agents, butyrophenone Those butyrophenone derivatives used in the treatment of psychoses.
(12 Dec 1998)
antipsychotic agents, phenothiazine Phenothiazine derivatives used in the treatment of psychoses.
(12 Dec 1998)
antirheumatic agents Drugs that are used to treat rheumatoid arthritis.
(12 Dec 1998)
antirheumatic agents, gold Gold salts that are effective in the therapy of rheumatoid arthritis. These compounds usually do not have analgesic activity. Since these compounds are poorly absorbed from the intestinal tract, they are usually given intramuscularly.
(12 Dec 1998)
antisickling agents Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions.
(12 Dec 1998)
antispermatogenic agents Agents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and block spermatogenesis.
(12 Dec 1998)
antithyroid agents Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones.
(12 Dec 1998)
antitreponemal agents Agents used to treat infections with bacteria of the genus treponema. This includes syphylis & yaws.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • hot water system
    ½ºÆÀ¿ë ¹è°ü
  • hydraulic system
    À¯¾Ð ÀåÄ¡(°èÅë)(À¯¾ÐÀ¸·Î Á¶Á¾°èÅëÀ̳ª Âø·úÀåÄ¡¸¦ ÀÛµ¿½ÃŰ´Â
  • incompatible color(system)
    tv ºñ¾ç¸³½Ä(º¸Åë Èæ¹é ¼¼Æ®¿¡´Â ¼ö»óµÇÁö ¾Ê´Â Ä÷¯ ÅÚ·¹ºñÀü¹æ½Ä)
  • inertia navigation system
    °ü¼º Ç×¹ý ½Ã½ºÅÛ
  • information system
    Á¤º¸½Ã½ºÅÛ(ƯÈ÷)µ¥ÀÌŸó¸® ½Ã½ºÅÛ
  • instrument landing system
    (°ø)°è±âÂø·úÀåÄ¡(¹æ½Ä)
  • integrated system
    (ÀüÀÚ)ÁýÀû½Ã½ºÅÛ(ÁýÀûȸ·ÎÀü¹ÝÀ» °¡¸®Å´)
  • intercommunication system
    (¹è,ºñÇà±â,ÀüÂ÷µîÀÇ)³»ºÎÅëÈ­(ÀåÄ¡)ÀÎÅÍÄÞ;ÀÎÅÍÆù
  • lifesupport system
    »ý¸íÀ¯ÁöÀåÄ¡(¿ìÁÖ,ÇØÀú ŽÇè¿ë)
  • magnetic levitation propulsion system
    Àڱ⠺λó ÃßÁø ½Ã½ºÅÛ(linear motor¿¡ ÀÇÇÑ Ãʰí¼Ó öµµ)
  • management information system
    °æ¿µ Á¤º¸ ½Ã½ºÅÛ
  • mandatory retirement system
    Á¤³âÁ¦
  • manmachine system
    Àΰ£ ±â°è°è(Àΰ£ ¹× Àΰ£ÀÌ Á¶ÀÛÇÏ´Â ÀåÄ¡,±â°è¸¦ ±¸¼º ¿ä¼Ò·Î Çϴ ü°è);(ÇùÀÇ·Î)Àΰ£°ú ÄÄÇ»ÅÍ¿ÍÀÇ ´ëÈ­ Çü½Ä¿¡ µû¶ó ÀÛ¾÷À» ÁøÇàÇÏ´Â ½Ã½ºÅÛ
  • marketing information system
    ¸¶ÄÉÆÃ Á¤º¸ ½Ã½ºÅÛ
  • matrix system
    ¸ÅÆ®¸¯½º ½Ã½ºÅÛ (Á¾Àû Á¶Á÷ »Ó ¾Æ´Ï¶ó ȾÀû ÇÁ·ÎÁ§Æ® ÆÀÀÇ ÀÏ¿øµµ µÇ°Ô ÇÏ´Â °æ¿µ ½Ã½ºÅÛ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á